These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30628773)

  • 1. Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular Delivery of Functional siRNA to Triple Negative Breast Cancer Cells.
    Biswas A; Chakraborty K; Dutta C; Mukherjee S; Gayen P; Jan S; Mallick AM; Bhattacharyya D; Sinha Roy R
    ACS Appl Mater Interfaces; 2019 Feb; 11(5):4719-4736. PubMed ID: 30628773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
    Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
    Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer.
    Yang YY; Zhang W; Liu H; Jiang JJ; Wang WJ; Jia ZY
    Drug Des Devel Ther; 2021; 15():4961-4972. PubMed ID: 34916779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuning Peptide-Based Nanofibers for Achieving Selective Doxorubicin Delivery in Triple-Negative Breast Cancer.
    Bellavita R; Piccolo M; Leone L; Ferraro MG; Dardano P; De Stefano L; Nastri F; Irace C; Falanga A; Galdiero S
    Int J Nanomedicine; 2024; 19():6057-6084. PubMed ID: 38911501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide.
    Lee YW; Hwang YE; Lee JY; Sohn JH; Sung BH; Kim SC
    J Microbiol Biotechnol; 2018 Mar; 28(3):367-374. PubMed ID: 29316746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivo.
    Tai Z; Wang X; Tian J; Gao Y; Zhang L; Yao C; Wu X; Zhang W; Zhu Q; Gao S
    Biomacromolecules; 2015 Apr; 16(4):1119-30. PubMed ID: 25686200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA delivery.
    Xie D; Du J; Bao M; Zhou A; Tian C; Xue L; Ju C; Shen J; Zhang C
    Biomater Sci; 2019 Feb; 7(3):901-913. PubMed ID: 30575823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lauroylated Histidine-Enriched S4
    Morais CM; Cardoso AM; Aguiar L; Vale N; Nóbrega C; Zuzarte M; Gomes P; Pedroso de Lima MC; Jurado AS
    Pharm Res; 2020 Sep; 37(10):188. PubMed ID: 32888084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
    Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
    Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
    Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
    Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
    Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
    Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy.
    Jing H; Cheng W; Li S; Wu B; Leng X; Xu S; Tian J
    Colloids Surf B Biointerfaces; 2016 Oct; 146():387-95. PubMed ID: 27388967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal and magnetic dual-responsive liposomes with a cell-penetrating peptide-siRNA conjugate for enhanced and targeted cancer therapy.
    Yang Y; Xie X; Xu X; Xia X; Wang H; Li L; Dong W; Ma P; Yang Y; Liu Y; Mei X
    Colloids Surf B Biointerfaces; 2016 Oct; 146():607-15. PubMed ID: 27429294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy.
    Wang X; Wu F; Li G; Zhang N; Song X; Zheng Y; Gong C; Han B; He G
    Acta Biomater; 2018 Jul; 74():414-429. PubMed ID: 29787814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine-Rich Cationic Cell-Penetrating Peptides for Plasmid DNA and siRNA Delivery.
    Kichler A; Mason AJ; Marquette A; Bechinger B
    Methods Mol Biol; 2019; 1943():39-59. PubMed ID: 30838608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
    Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
    Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
    Furukawa K; Tanaka M; Oba M
    Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Evaluation of Homochiral Peptides Containing Arginine and Histidine as Molecular Transporters.
    El-Sayed NS; Miyake T; Shirazi AN; Park SE; Clark J; Buchholz S; Parang K; Tiwari R
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29966296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.